Immunomodulatory therapy in genetic mouse models of progressive multiple sclerosis

被引：0
|
作者：
Groh, J. [1 ]
Hoerner, M. [1 ]
Buttmann, M. [2 ]
Martini, R. [1 ]
机构：
[1] Univ Hosp Wuerzburg, Dept Neurol, Dev Neurobiol, Wurzburg, Germany
[2] Univ Hosp Wuerzburg, Dept Neurol, Wurzburg, Germany
来源：
MULTIPLE SCLEROSIS JOURNAL | 2017年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P430
引用
收藏
页码：177 / 177
页数：1
相关论文
共 50 条
  • [21] Pharmacogenetics of multiple sclerosis: personalized therapy with immunomodulatory drugs
    Tsareva, Ekaterina
    Kulakova, Olga
    Boyko, Alexey
    Favorova, Olga
    PHARMACOGENETICS AND GENOMICS, 2016, 26 (03): : 103 - 115
  • [22] Transgenic mouse models of multiple sclerosis
    Scheikl, Tanja
    Pignolet, Beatrice
    Mars, Lennart T.
    Liblau, Roland S.
    CELLULAR AND MOLECULAR LIFE SCIENCES, 2010, 67 (23) : 4011 - 4034
  • [23] Transgenic mouse models of multiple sclerosis
    Tanja Scheikl
    Béatrice Pignolet
    Lennart T. Mars
    Roland S. Liblau
    Cellular and Molecular Life Sciences, 2010, 67 : 4011 - 4034
  • [24] Selective Immunomodulatory and Neuroprotective Effects of a NOD2 Receptor Agonist on Mouse Models of Multiple Sclerosis
    Fani Maleki, Adham
    Cisbani, Giulia
    Laflamme, Nataly
    Prefontaine, Paul
    Plante, Marie-Michele
    Baillargeon, Joanie
    Rangachari, Manu
    Gosselin, Jean
    Rivest, Serge
    NEUROTHERAPEUTICS, 2021, 18 (02) : 889 - 904
  • [25] A comparative study of melatonin and immunomodulatory therapy with interferon beta and glatiramer acetate in a mouse model of multiple sclerosis
    Gonzalez, E. J. Ramos
    Jirano, L. J. Ramirez
    Martinez, D. Z. Garcia
    Ortiz, G. G.
    Suarez, L. F. Jave
    Cortes, C. A. Leal
    Quintero, O. K. Bitzer
    NEUROLOGIA, 2021, 36 (04): : 262 - 270
  • [26] Progranulin genetic variability in primary progressive multiple sclerosis
    Fenoglio, C.
    Galimberti, A.
    Martinelli-Boneschi, F.
    Scalabrini, D.
    Esposito, F.
    De Riz, M.
    Piccio, L.
    Comi, C.
    Pietroboni, A.
    Piola, M.
    Venturelli, E.
    Cortini, F.
    Villa, C.
    Serpente, M.
    Leone, M.
    Bresolin, N.
    Cross, A.
    Comi, G.
    Scarpini, E.
    JOURNAL OF NEUROLOGY, 2009, 256 : S235 - S235
  • [27] Progranulin genetic variability in primary progressive multiple sclerosis
    Fenoglio, C.
    Esposito, F.
    Galimberti, D.
    Scalabrini, D.
    Martinelli, V.
    Rodegher, M. E.
    De Riz, M.
    Piccio, L.
    Comi, C.
    Venturelli, E.
    Cortini, F.
    Villa, C.
    Bresolin, N.
    Cross, A.
    Comi, G.
    Scarpini, E.
    Martinelli-Boneschi, F.
    MULTIPLE SCLEROSIS, 2009, 15 (09): : S187 - S187
  • [28] Training program for patients with multiple sclerosis at the start of immunomodulatory therapy
    Harto-Castano, Adela
    ENFERMERIA CLINICA, 2007, 17 (05): : 267 - 271
  • [29] Escalating immunomodulatory therapy of multiple sclerosis -: 1.: Supplement
    Büttner, U
    Chofflon, M
    Hess, K
    Kappos, L
    Kesselring, J
    Ludin, HP
    Schluep, M
    Vaney, C
    Baumhackl, U
    Berger, T
    Deisenhammer, F
    Freimüller, M
    Hartung, HP
    Kollegger, H
    Kristoferitsch, W
    Lassmann, H
    Markut, H
    Vass, K
    Altenkirch, H
    Boese, J
    Gass, A
    Gehlen, W
    Goebels, N
    Haas, J
    Haferkamp, G
    Heidenreich, F
    Heitmann, R
    Hemmer, B
    Hohlfeld, R
    Janzen, RWC
    Jügelt, E
    Kölmel, W
    König, N
    Kowitzsch, K
    Manegold, U
    Melms, A
    Mertin, J
    Petereit, HF
    Pette, M
    Pöhlau, D
    Poser, S
    Sailer, M
    Schmidt, S
    Schock, G
    Schulz, M
    Seidel, D
    Stangel, M
    Stark, E
    Stoll, G
    Weinrich, W
    NERVENARZT, 2001, 72 (02): : 150 - 157
  • [30] Effects of immunomodulatory therapy on memory functioning in multiple sclerosis patients
    Drake, M
    Carra, A
    Allegri, R
    MULTIPLE SCLEROSIS, 2005, 11 : S72 - S72
12345